S N Pandit Ayurvedic Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 1.00 M
as on 21-12-2024
- Company Age 24 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.34 Cr
as on 21-12-2024
- Revenue 86.59%
(FY 2019)
- Profit 60.40%
(FY 2019)
- Ebitda 111.68%
(FY 2019)
- Net Worth 13.09%
(FY 2019)
- Total Assets 41.58%
(FY 2019)
About S N Pandit Ayurvedic Company
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.34 Cr.
Karthik Yoganarasimhaiah, Ranjani Pandit, and Pandit Susheela serve as directors at the Company.
- CIN/LLPIN
U24231KA1999PTC026167
- Company No.
026167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at S N Pandit Ayurvedic Company?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjani Pandit  | Whole-Time Director | 01-Nov-2016 | Current |
| Karthik Yoganarasimhaiah | Director | 31-Dec-1999 | Current |
| Pandit Susheela | Director | 31-Dec-1999 | Current |
Financial Performance of S N Pandit Ayurvedic Company.
S N Pandit Ayurvedic Company Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 86.59% increase. The company also saw a substantial improvement in profitability, with a 60.4% increase in profit. The company's net worth Soared by an impressive increase of 13.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S N Pandit Ayurvedic Company?
In 2019, S N Pandit Ayurvedic Company had a promoter holding of 98.00% and a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S N Pandit Healthcare Services LlpActive 10 years 3 monthsKarthik Yoganarasimhaiah, Ranjani Pandit and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 13 Jul 2000 | ₹1.34 Cr | Open |
How Many Employees Work at S N Pandit Ayurvedic Company?
Unlock and access historical data on people associated with S N Pandit Ayurvedic Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S N Pandit Ayurvedic Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S N Pandit Ayurvedic Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
